Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lipodystrophies].

Pamela Fischer-Posovszky1, K M Debatin, M Wabitsch

  • 1Universitätskinderklinik und Poliklinik, Ulm, Germany.

Klinische Padiatrie
|May 17, 2002
PubMed
Summary
This summary is machine-generated.

Lipodystrophy syndromes involve rare adipose tissue loss from genetic or acquired causes, leading to severe metabolic issues like diabetes. Recent research identifies causative mutations and explores new therapeutic strategies for these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upregulation of miR-146a-5p and miR-146b-5p limits IL-1β-mediated signaling in adipose tissue during polytrauma by downregulating IRAK1.

Frontiers in immunology·2026
Same author

Development of an integrative cross-omics approach for conceptual adverse outcome pathway network construction.

Environment international·2026
Same author

Making a droplet: the adipogenin-seipin complex at work.

Nature reviews. Endocrinology·2026
Same author

Response to "Co-Culture Shock" by Behan & Mittelman: Co-culture shock? Let's integrate!

Cell death discovery·2026
Same author

Adipose tissue-derived microRNAs as epigenetic modulators of type 2 diabetes.

BMC medicine·2025
Same author

Pioglitazone modulates metabolic adaptation and peripheral nerve regeneration after injury.

Molecular neurodegeneration·2025

Area of Science:

  • Endocrinology and Metabolism
  • Genetics
  • Rare Diseases

Context:

  • Lipodystrophy syndromes are rare genetic or acquired disorders characterized by generalized or partial loss of adipose tissue.
  • These conditions lead to significant metabolic complications, including insulin resistance, diabetes mellitus, hypertriglyceridemia, and hepatic steatosis.
  • Understanding the diverse etiologies and pathogenic mechanisms is crucial for effective management.

Purpose:

  • To present the recently updated classification of lipodystrophy syndromes.
  • To review new insights into the pathogenesis of these rare disorders.
  • To discuss emerging therapeutic strategies for managing lipodystrophy and its associated metabolic complications.

Summary:

  • This review details the classification of lipodystrophy syndromes, encompassing both familial and acquired forms.

Related Experiment Videos

  • It highlights recent discoveries in causative gene mutations for specific lipodystrophy types.
  • The article also explores the utility of mouse models in understanding disease development and discusses current and future therapeutic approaches.

    • Impact:

    • Provides an updated framework for classifying lipodystrophy syndromes, aiding diagnosis and research.
    • Offers novel insights into the molecular basis and progression of lipodystrophy.
    • Informs the development of targeted therapies to improve metabolic outcomes and patient quality of life.